Table 8.

Results of 5-HT1A mRNA and SERT levels in the hippocampus and hypothalamus of foetuses

Groups	n	Position	5-HT1A mRNA(× 10-2)	SERT
Female foetuses of control	47	Hippocampus	0.284 ± 0.051	0.312 ± 0.069
			(0.269~0.299)	(0.292~0.332)
		Hypothalamus	0.272 ± 0.031	0.342 ± 0.059
			(0.263~0.281)	(0.325~0.359)
Female foetuses of CUS	43	Hippocampus	0.223 ± 0.036**	0.213 ± 0.06**
			(0.212~0.234)	(0.194~0.232)
		Hypothalamus	0.266 ± 0.059	0.246 ± 0.037**
			(0.248~0.284)	(0.234~0.258)
Male foetuses of control	40	Hippocampus	0.288 ± 0.051	0.334 ± 0.042
			(0.272~0.304)	(0.320~0.348)
		Hypothalamus	0.265 ± 0.044	0.351 ± 0.046
			(0.251~0.279)	(0.336~0.366)
Male foetuses of CUS	49	Hippocampus	0.233 ± 0.042**	0.226 ± 0.034**
			(0.221~0.245)	(0.216~0.236)
		Hypothalamus	0.275 ± 0.028	0.235 ± 0.055**
			(0.267~0.283)	(0.219~0.251)

Data are mean ± S.D. Data in bracket are 95% confidence intervals for each relevant statistic. 5-HT1A mRNA levels are the relative level of 5-HT1A to GAPDH. SERT levels are the relative level of SERT to β-actin. **: P < 0.01 compared with control by the same sex and the same position